Alkermes, Inc. · Waltham, MA United States
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowCompany Description
Alkermes is working some medicinal alchemy. The firm uses its proprietary drug-delivery systems to make compounds that require less frequent dosing or provide more targeted delivery. Focusing on widespread diseases like diabetes, central nervous system disorders, and addiction, it has a couple of drugs on the market that use its injectable extended-release technology, which lets patients take a drug once or twice a month, rather than once or twice a day. One such drug is Risperdal Consta, a long-acting version of Johnson & Johnson's schizophrenia medication Risperdal. Another is Vivitrol, a treatment for alcohol dependence. Alkermes, Inc. merged with Elan Drug Technologies in 2011 to form Alkermes plc.

Alkermes, Inc. Reports

No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Top Alkermes, Inc. Competitors